COLORADO SPRINGS -- Pediatric nonalcoholic fatty liver disease is strongly associated with multiple cardiovascular risk factors, often in excess of clinical thresholds for considering pharmacotherapy, Dr. Stephen Cook said at a conference of the American Heart Association.
Moreover, the prevalence of metabolic syndrome in children and adolescents with nonalcoholic fatty liver disease (NAFLD) is twice that seen in equally obese youths without the hepatic disease, according to Dr. Cook, a pediatrician at the University of Rochester (N.Y.) Medical Center.
[ILLUSTRATION OMITTED]
He added that these new findings from a 300-patient case-control study underscore the ...